Free Trial
NASDAQ:BTMD

biote Q1 2025 Earnings Report

biote logo
$3.27 -0.06 (-1.80%)
Closing price 05/1/2025 04:00 PM Eastern
Extended Trading
$3.32 +0.05 (+1.56%)
As of 04:58 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

biote EPS Results

Actual EPS
N/A
Consensus EPS
$0.06
Beat/Miss
N/A
One Year Ago EPS
N/A

biote Revenue Results

Actual Revenue
N/A
Expected Revenue
$47.25 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

biote Announcement Details

Quarter
Q1 2025
Time
After Market Closes
Conference Call Date
Wednesday, May 7, 2025
Conference Call Time
5:00PM ET

Conference Call Resources

biote Earnings Headlines

Jefferies Reaffirms Their Buy Rating on biote (BTMD)
Silicon Valley Gold Rush
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
Marc Beer Buys Handful Of Shares In biote
biote (BTMD) Gets a Buy from Craig-Hallum
See More biote Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like biote? Sign up for Earnings360's daily newsletter to receive timely earnings updates on biote and other key companies, straight to your email.

About biote

biote (NASDAQ:BTMD) operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.

View biote Profile

More Earnings Resources from MarketBeat